Association of
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
07
2022
accepted:
03
08
2022
entrez:
23
8
2022
pubmed:
24
8
2022
medline:
25
8
2022
Statut:
epublish
Résumé
Glioma is the most common intracranial malignancy.
Identifiants
pubmed: 35996546
doi: 10.1155/2022/2712808
pmc: PMC9392611
doi:
Substances chimiques
TP53 protein, human
0
Tumor Suppressor Protein p53
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2712808Informations de copyright
Copyright © 2022 Fan Liao et al.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest regarding the publication of this paper.
Références
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
Prog Neurol Surg. 2018;30:1-11
pubmed: 29241168
J Neurooncol. 2014 May;118(1):131-9
pubmed: 24590827
Neuro Oncol. 2014 Jul;16(7):896-913
pubmed: 24842956
Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3850-3856
pubmed: 28975980
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):467-478
pubmed: 28513632
Iran J Public Health. 2014 Apr;43(4):453-9
pubmed: 26005655
Nat Genet. 2017 May;49(5):789-794
pubmed: 28346443
Nat Genet. 2009 Aug;41(8):905-8
pubmed: 19578366
Blood. 2021 Dec 23;138(25):2670-2685
pubmed: 33945616
Exp Mol Pathol. 2011 Apr;90(2):167-72
pubmed: 21115003
Nat Genet. 2012 Oct;44(10):1122-5
pubmed: 22922872
Tumour Biol. 2013 Oct;34(5):3121-30
pubmed: 23860773
Cancers (Basel). 2018 Aug 25;10(9):
pubmed: 30149602
Acta Neuropathol. 2018 May;135(5):743-755
pubmed: 29460007
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13550-5
pubmed: 16141321
Genet Mol Res. 2008 Feb 26;7(1):207-16
pubmed: 18393224
Mol Cancer. 2017 Jun 7;16(1):100
pubmed: 28592260
J Cell Mol Med. 2009 Mar;13(3):440-53
pubmed: 19379143
Front Oncol. 2018 Sep 26;8:413
pubmed: 30319976
Tumour Biol. 2014 Apr;35(4):3725-30
pubmed: 24488625
Nat Genet. 2012 Oct;44(10):1111-6
pubmed: 22941189
Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):98-103
pubmed: 15950766
Acta Neuropathol. 2004 Jul;108(1):49-56
pubmed: 15118874
Int J Clin Exp Pathol. 2015 Mar 01;8(3):3198-203
pubmed: 26045840
Cold Spring Harb Perspect Biol. 2010 Mar;2(3):a001016
pubmed: 20300207
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Oncotarget. 2016 Jul 26;7(30):47918-47926
pubmed: 27374106
Lancet Oncol. 2009 Aug;10(8):772-84
pubmed: 19625214
J Hematol Oncol. 2022 Jul 13;15(1):91
pubmed: 35831864
Cancer Biother Radiopharm. 2013 Apr;28(3):248-53
pubmed: 23573956
Int J Mol Sci. 2019 Dec 08;20(24):
pubmed: 31817996
Cell. 2017 Sep 7;170(6):1062-1078
pubmed: 28886379
Clin Transl Oncol. 2021 Apr;23(4):840-845
pubmed: 32839927
Nat Genet. 2012 Oct;44(10):1104-10
pubmed: 22941188
Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2220-3
pubmed: 16172235
Med Oncol. 2014 Dec;31(12):356
pubmed: 25412941
Cell Death Differ. 2019 Mar;26(3):409-425
pubmed: 29786075
Nature. 2014 May 1;509(7498):91-5
pubmed: 24670651
Onco Targets Ther. 2017 Feb 23;10:1149-1154
pubmed: 28260929
Nature. 2008 Oct 23;455(7216):1061-8
pubmed: 18772890
Cancer Biomark. 2015;15(4):459-65
pubmed: 25835179
Cancer Genet Cytogenet. 2008 Jan 1;180(1):14-9
pubmed: 18068527
Oncol Lett. 2021 Sep;22(3):659
pubmed: 34386081
Mol Ther Oncolytics. 2021 Jan 05;20:199-208
pubmed: 33665358
J Clin Oncol. 2018 Feb 20;36(6):591-599
pubmed: 29300620
Transl Oncol. 2019 Oct;12(10):1282-1288
pubmed: 31325764
Neurology. 2009 Jan 27;72(4):332-6
pubmed: 19171829
Hum Mol Genet. 2011 Jul 15;20(14):2897-904
pubmed: 21531791
J Cancer. 2019 Jan 1;10(2):467-471
pubmed: 30719141
Nat Commun. 2015 Oct 01;6:8559
pubmed: 26424050
Breast Cancer. 2017 Jul;24(4):571-578
pubmed: 27837441